Cargando…
Synergistic Effect between Cisplatin and Sunitinib Malate on Human Urinary Bladder-Cancer Cell Lines
The aim of this paper is to analyse sunitinib malate in vitro ability to enhance cisplatin cytotoxicity in T24, 5637, and HT1376 human urinary bladder-cancer cell lines. Cells were treated with cisplatin (3, 6, 13, and 18 μM) and sunitinib malate (1, 2, 4, 6, and 20 μM), either in isolation or combi...
Autores principales: | Arantes-Rodrigues, Regina, Pinto-Leite, Rosário, Fidalgo-Gonçalves, Lio, Palmeira, Carlos, Santos, Lúcio, Colaço, Aura, Oliveira, Paula |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3863483/ https://www.ncbi.nlm.nih.gov/pubmed/24369536 http://dx.doi.org/10.1155/2013/791406 |
Ejemplares similares
-
The effect of cisplatin in 5637 bladder cancer cell line
por: Pinto-Leite, Rosário, et al.
Publicado: (2010) -
Sunitinib Malate Synergistically Potentiates Anti-Tumor Effect of Gemcitabine in Human Bladder Cancer Cells
por: Yoon, Cheol Yong, et al.
Publicado: (2011) -
Guillain-Barré Syndrome following Treatment with Sunitinib Malate
por: Kanaan, Ziad, et al.
Publicado: (2014) -
Vesicocutaneous fistula formation during treatment with sunitinib malate: Case report
por: Watanabe, Koichiro, et al.
Publicado: (2010) -
Human urothelial carcinoma cell response to Sunitinib malate therapy in vitro
por: Wen, Jin, et al.
Publicado: (2015)